LUKE T NORDQUIST M.D. NPI 1538149414

NPI Information

  • NPI: 1538149414
  • Provider Name: LUKE T NORDQUIST, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 17607 GOLD PLZ
    OMAHA, NE
    ZIP 68130
  • Phone: (402) 991-8468

Map and Directions

Get Directions

NPI Details

Luke T Nordquist, M.D. is a hematology and oncology internal medicine in Omaha, NE with 28 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Luke T Nordquist, M.D. NPI is 1538149414. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1998

The provider's business location address is:

17607 GOLD PLZ
OMAHA, NE
ZIP 68130-606
Phone: (402) 991-8468
Fax: (402) 991-8469

The NPI 1538149414 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, bevacizumab, 10 mg (HCPCS:J9035)
  • Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie (HCPCS:A9607)
  • Injection, cabazitaxel, 1 mg (HCPCS:J9043)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Blood creatinine level (HCPCS:82565)
  • Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie (HCPCS:A9596)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Automated urinalysis test (HCPCS:81003)
  • Radioactive drug therapy through a vein (HCPCS:79101)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Unclassified drugs (HCPCS:J3490)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Radiopharmaceutical, therapeutic, not otherwise classified (HCPCS:A9699)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)

The enumeration date for this NPI number is 1/18/2006 and was last updated on 4/16/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology22733NEBRASKAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.